SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001823239-22-000044
Filing Date
2022-08-05
Accepted
2022-08-05 16:12:05
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrvi-20220630.htm   iXBRL 10-Q 2322385
2 EX-31.1 mrvi-q22022form10xqxex311x.htm EX-31.1 8201
3 EX-31.2 mrvi-q22022form10xqxex312x.htm EX-31.2 8228
4 EX-32.1 mrvi-q22022xform10xqxex321.htm EX-32.1 4089
5 EX-32.2 mrvi-q22022xform10xqxex322.htm EX-32.2 4065
  Complete submission text file 0001823239-22-000044.txt   10444163

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20220630.xsd EX-101.SCH 52708
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrvi-20220630_cal.xml EX-101.CAL 102674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrvi-20220630_def.xml EX-101.DEF 361594
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20220630_lab.xml EX-101.LAB 660309
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20220630_pre.xml EX-101.PRE 511573
78 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20220630_htm.xml XML 2139781
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39725 | Film No.: 221140954
SIC: 2834 Pharmaceutical Preparations